Last 12 months
Inside the activity.
1 purchase rows · 62 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 20 |
| Jan 2026 | 1 | 20 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 23, 2025 Filed Dec 31, 2025 02:03 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 6,831 | $6.27 | $42,830.37 |
DisclosureSEC source: 0001835544-25-000005 · primary_doc.xml · nonDerivative · entry 2 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 800,664 Read SEC document |
| December 23, 2025 Filed Dec 31, 2025 02:03 UTC |
Ugwumba Chidozie10% owner
|
OtherCommon Stock | 424,358 | $0.00 | $424.36 |
DisclosureSEC source: 0001835544-25-000005 · primary_doc.xml · nonDerivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 807,495 F1 · balance_after: In connection with the cashless exercise of the pre-funded warrants, the issuer withheld shares of common stock to satisfy the $0.001 per-share exercise price, resulting in the issuance of fewer shares than the number of shares underlying the warrants exercised. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:37 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 4,367 | $6.54 | $28,560.18 |
DisclosureSEC source: 0001835544-25-000004 · primary_doc.xml · nonDerivative · entry 2 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 383,201 Read SEC document |
| December 19, 2025 Filed Dec 23, 2025 21:37 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 5,582 | $6.45 | $36,003.90 |
DisclosureSEC source: 0001835544-25-000004 · primary_doc.xml · nonDerivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 387,568 Read SEC document |
| December 18, 2025 Filed Dec 18, 2025 22:08 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 5,816 | $6.33 | $36,815.28 |
DisclosureSEC source: 0001835544-25-000002 · primary_doc.xml · nonDerivative · entry 12 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 393,150 Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 22:08 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 2,884 | $6.61 | $19,063.24 |
DisclosureSEC source: 0001835544-25-000002 · primary_doc.xml · nonDerivative · entry 11 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 398,966 Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 22:08 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 7,030 | $6.31 | $44,359.30 |
DisclosureSEC source: 0001835544-25-000002 · primary_doc.xml · nonDerivative · entry 10 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 401,850 Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 22:08 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 10,580 | $6.49 | $68,664.20 |
DisclosureSEC source: 0001835544-25-000002 · primary_doc.xml · nonDerivative · entry 9 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 408,880 Read SEC document |
| December 12, 2025 Filed Dec 18, 2025 22:08 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 7,603 | $6.79 | $51,624.37 |
DisclosureSEC source: 0001835544-25-000002 · primary_doc.xml · nonDerivative · entry 8 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 419,460 Read SEC document |
| December 11, 2025 Filed Dec 18, 2025 22:08 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 10,907 | $6.81 | $74,276.67 |
DisclosureSEC source: 0001835544-25-000002 · primary_doc.xml · nonDerivative · entry 7 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 427,063 Read SEC document |
| December 10, 2025 Filed Dec 18, 2025 22:08 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 9,921 | $6.42 | $63,692.82 |
DisclosureSEC source: 0001835544-25-000002 · primary_doc.xml · nonDerivative · entry 6 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 437,970 Read SEC document |
| December 09, 2025 Filed Dec 18, 2025 22:08 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 15,031 | $5.95 | $89,434.45 |
DisclosureSEC source: 0001835544-25-000002 · primary_doc.xml · nonDerivative · entry 5 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 447,891 Read SEC document |
| December 08, 2025 Filed Dec 18, 2025 22:08 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 21,463 | $5.70 | $122,339.10 |
DisclosureSEC source: 0001835544-25-000002 · primary_doc.xml · nonDerivative · entry 4 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 462,922 Read SEC document |
| December 05, 2025 Filed Dec 18, 2025 22:08 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 37,235 | $5.94 | $221,175.90 |
DisclosureSEC source: 0001835544-25-000002 · primary_doc.xml · nonDerivative · entry 3 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 484,385 Read SEC document |
| December 04, 2025 Filed Dec 18, 2025 22:08 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 72,748 | $6.73 | $489,594.04 |
DisclosureSEC source: 0001835544-25-000002 · primary_doc.xml · nonDerivative · entry 2 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 521,620 Read SEC document |
| December 03, 2025 Filed Dec 18, 2025 22:08 UTC |
Ugwumba Chidozie10% owner
|
SaleCommon Stock | 56,577 | $7.86 | $444,695.22 |
DisclosureSEC source: 0001835544-25-000002 · primary_doc.xml · nonDerivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Symbiosis II, LLC Disclosed balance after: 594,368 Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:48 UTC |
Kiernan MatthewDirector
|
Grantstock option · Derivative | 1,893 | $0.00 Strike: $7.30 | $0.00 |
DisclosureSEC source: 0001437749-25-035232 · rdgdoc.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,893 Underlying: common stock · 1,893 shares Expires 2035-11-12 F1 · derivative.exercise_date: This option was granted on November 13, 2025 as an option for 1,893 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:43 UTC |
McLaughlin VallerieDirector
|
Grantstock option · Derivative | 2,083 | $0.00 Strike: $7.30 | $0.00 |
DisclosureSEC source: 0001437749-25-035224 · rdgdoc.xml · derivative · entry 1 McLaughlin Vallerie · CIK 0001876030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,083 Underlying: common stock · 2,083 shares Expires 2035-11-12 F1 · derivative.exercise_date: This option was granted on November 13, 2025 as an option for 2,083 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:47 UTC |
Gay JonathonDirector
|
Grantstock option · Derivative | 2,438 | $0.00 Strike: $7.30 | $0.00 |
DisclosureSEC source: 0001437749-25-035231 · rdgdoc.xml · derivative · entry 1 Gay Jonathon · CIK 0001835422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,438 Underlying: common stock · 2,438 shares Expires 2035-11-12 F1 · derivative.exercise_date: This option was granted on November 13, 2025 as an option for 2,438 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:42 UTC |
WILCOX REED NDirector
|
Grantstock option · Derivative | 1,893 | $0.00 Strike: $7.30 | $0.00 |
DisclosureSEC source: 0001437749-25-035223 · rdgdoc.xml · derivative · entry 1 WILCOX REED N · CIK 0001266609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,893 Underlying: common stock · 1,893 shares Expires 2035-11-12 F1 · derivative.exercise_date: This option was granted on November 13, 2025 as an option for 1,893 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:45 UTC |
MATLIN DAVID JDirector
|
Grantstock option · Derivative | 3,692 | $0.00 Strike: $7.30 | $0.00 |
DisclosureSEC source: 0001437749-25-035226 · rdgdoc.xml · derivative · entry 1 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,692 Underlying: common stock · 3,692 shares Expires 2035-11-12 F1 · derivative.exercise_date: This option was granted on November 13, 2025 as an option for 3,692 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:46 UTC |
Mosca AlisonDirector
|
Grantstock option · Derivative | 2,887 | $0.00 Strike: $7.30 | $0.00 |
DisclosureSEC source: 0001437749-25-035230 · rdgdoc.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,887 Underlying: common stock · 2,887 shares Expires 2035-11-12 F1 · derivative.exercise_date: This option was granted on November 13, 2025 as an option for 2,887 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:45 UTC |
Jacobovitz ShalomDirector
|
Grantstock option · Derivative | 2,816 | $0.00 Strike: $7.30 | $0.00 |
DisclosureSEC source: 0001437749-25-035229 · rdgdoc.xml · derivative · entry 1 Jacobovitz Shalom · CIK 0001835556 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,816 Underlying: common stock · 2,816 shares Expires 2035-11-12 F1 · derivative.exercise_date: This option was granted on November 13, 2025 as an option for 2,816 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:44 UTC |
Desai Arjun JJDirector
|
Grantstock option · Derivative | 2,177 | $0.00 Strike: $7.30 | $0.00 |
DisclosureSEC source: 0001437749-25-035225 · rdgdoc.xml · derivative · entry 1 Desai Arjun JJ · CIK 0001982985 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,177 Underlying: common stock · 2,177 shares Expires 2035-11-12 F1 · derivative.exercise_date: This option was granted on November 13, 2025 as an option for 2,177 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant. Read SEC document |
| September 25, 2025 Filed Sep 29, 2025 20:13 UTC |
Mortenson MarkChief Science Officer
|
Grantstock option · Derivative | 40,000 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0001437749-25-030019 · rdgdoc.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: common stock · 40,000 shares Expires 2035-09-24 F1 · derivative.exercise_date: This option was granted on September 25, 2025 as an option for 40,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.05 per share. The options vest in 12 equal monthly installments on the 25th day of each calendar month, beginning October 25, 2025, until such shares are fully vested. Read SEC document |
| September 25, 2025 Filed Sep 29, 2025 20:10 UTC |
BROWN MORGAN RChief Financial Officer
|
Grantstock option · Derivative | 10,000 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0001437749-25-030014 · rdgdoc.xml · derivative · entry 1 BROWN MORGAN R · CIK 0001266062 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: common stock · 10,000 shares Expires 2035-09-24 F1 · derivative.exercise_date: This option was granted on September 25, 2025 as an option for 10,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.05 per share. The options vest in 12 equal monthly installments on the 25th day of each calendar month, beginning October 25, 2025, until such shares are fully vested. Read SEC document |
| September 25, 2025 Filed Sep 29, 2025 20:11 UTC |
Etherington Robert DeeDirector · President & CEO
|
Grantstock option · Derivative | 40,000 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0001437749-25-030016 · rdgdoc.xml · derivative · entry 1 Etherington Robert Dee · CIK 0001835330 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: common stock · 40,000 shares Expires 2035-09-24 F1 · derivative.exercise_date: This option was granted on September 25, 2025 as an option for 40,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.05 per share. The options vest in 12 equal monthly installments on the 25th day of each calendar month, beginning October 25, 2025, until such shares are fully vested. Read SEC document |
| September 25, 2025 Filed Sep 30, 2025 19:59 UTC Amendment |
Mortenson MarkChief Science Officer
|
Grantstock option · Derivative | 40,000 | $0.00 Strike: $5.88 | $0.00 |
DisclosureSEC source: 0001437749-25-030109 · rdgdoc.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: common stock · 40,000 shares Expires 2035-09-24 F1 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on September 29, 2025. The corrected exercise price is $5.88 per share. F2 · derivative.exercise_date: This option was granted on September 25, 2025 as an option for 40,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.88 per share. The options vest in 12 equal monthly installments on the 25th day of each calendar month, beginning October 25, 2025, until such shares are fully vested. Read SEC document |
| September 25, 2025 Filed Sep 30, 2025 19:56 UTC Amendment |
Etherington Robert DeeDirector · President & CEO
|
Grantstock option · Derivative | 40,000 | $0.00 Strike: $5.88 | $0.00 |
DisclosureSEC source: 0001437749-25-030107 · rdgdoc.xml · derivative · entry 1 Etherington Robert Dee · CIK 0001835330 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: common stock · 40,000 shares Expires 2035-09-24 F1 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on September 29, 2025. The corrected exercise price is $5.88 per share. F2 · derivative.exercise_date: This option was granted on September 25, 2025 as an option for 40,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.88 per share. The options vest in 12 equal monthly installments on the 25th day of each calendar month, beginning October 25, 2025, until such shares are fully vested. Read SEC document |
| September 18, 2025 Filed Sep 19, 2025 19:48 UTC |
Mortenson MarkChief Science Officer
|
Grantstock option · Derivative | 10,000 | $0.00 Strike: $6.32 | $0.00 |
DisclosureSEC source: 0001437749-25-029474 · rdgdoc.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: common stock · 10,000 shares Expires 2035-09-17 F1 · derivative.exercise_date: This option was granted on September 18, 2025 as an option for 10,000 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.32 per share. The options vest immediately upon grant. Read SEC document |
| September 18, 2025 Filed Sep 19, 2025 19:51 UTC |
BROWN MORGAN RChief Financial Officer
|
Grantstock option · Derivative | 10,000 | $0.00 Strike: $6.32 | $0.00 |
DisclosureSEC source: 0001437749-25-029477 · rdgdoc.xml · derivative · entry 1 BROWN MORGAN R · CIK 0001266062 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: common stock · 10,000 shares Expires 2035-09-17 F1 · derivative.exercise_date: This option was granted on September 18, 2025 as an option for 10,000 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.32 per share. The options vest immediately upon grant. Read SEC document |
| September 18, 2025 Filed Sep 19, 2025 19:54 UTC |
Etherington Robert DeeDirector · President & CEO
|
Grantstock option · Derivative | 10,000 | $0.00 Strike: $6.32 | $0.00 |
DisclosureSEC source: 0001437749-25-029480 · rdgdoc.xml · derivative · entry 1 Etherington Robert Dee · CIK 0001835330 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: common stock · 10,000 shares Expires 2035-09-17 F1 · derivative.exercise_date: This option was granted on September 18, 2025 as an option for 10,000 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.32 per share. The options vest immediately upon grant. Read SEC document |
| August 21, 2025 Filed Aug 21, 2025 20:44 UTC |
General Resonance LLC10% owner
|
SaleCommon Stock | 3,401 | $5.34 | $18,161.34 |
DisclosureSEC source: 0001641172-25-025124 · ownership.xml · nonDerivative · entry 1 General Resonance LLC · CIK 0001308627 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 704,591 Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 13:11 UTC |
Kiernan MatthewDirector
|
Grantstock option · Derivative | 3,720 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001437749-25-027073 · rdgdoc.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,720 Underlying: common stock · 3,720 shares Expires 2035-08-13 F1 · derivative.exercise_date: This option was granted on August 14, 2025 as an option for 3,720 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 13:14 UTC |
McLaughlin VallerieDirector
|
Grantstock option · Derivative | 4,092 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001437749-25-027075 · rdgdoc.xml · derivative · entry 1 McLaughlin Vallerie · CIK 0001876030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,092 Underlying: common stock · 4,092 shares Expires 2035-08-13 F1 · derivative.exercise_date: This option was granted on August 14, 2025 as an option for 4,092 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 12:59 UTC |
Gay JonathonDirector
|
Grantstock option · Derivative | 4,790 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001437749-25-027070 · rdgdoc.xml · derivative · entry 1 Gay Jonathon · CIK 0001835422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,790 Underlying: common stock · 4,790 shares Expires 2035-08-13 F1 · derivative.exercise_date: This option was granted on August 14, 2025 as an option for 4,790 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 12:49 UTC |
WILCOX REED NDirector
|
Grantstock option · Derivative | 3,720 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001437749-25-027067 · rdgdoc.xml · derivative · entry 1 WILCOX REED N · CIK 0001266609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,720 Underlying: common stock · 3,720 shares Expires 2035-08-13 F1 · derivative.exercise_date: This option was granted on August 14, 2025 as an option for 3,720 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 13:12 UTC |
MATLIN DAVID JDirector
|
Grantstock option · Derivative | 7,255 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001437749-25-027074 · rdgdoc.xml · derivative · entry 1 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,255 Underlying: common stock · 7,255 shares Expires 2035-08-13 F1 · derivative.exercise_date: This option was granted on August 14, 2025 as an option for 7,255 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 13:09 UTC |
Mosca AlisonDirector
|
Grantstock option · Derivative | 5,674 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001437749-25-027072 · rdgdoc.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,674 Underlying: common stock · 5,674 shares Expires 2035-08-13 F1 · derivative.exercise_date: This option was granted on August 14, 2025 as an option for 5,674 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 13:07 UTC |
Jacobovitz ShalomDirector
|
Grantstock option · Derivative | 5,534 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001437749-25-027071 · rdgdoc.xml · derivative · entry 1 Jacobovitz Shalom · CIK 0001835556 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,534 Underlying: common stock · 5,534 shares Expires 2035-08-13 F1 · derivative.exercise_date: This option was granted on August 14, 2025 as an option for 5,534 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 12:56 UTC |
Desai Arjun JJDirector
|
Grantstock option · Derivative | 4,278 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001437749-25-027069 · rdgdoc.xml · derivative · entry 1 Desai Arjun JJ · CIK 0001982985 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,278 Underlying: common stock · 4,278 shares Expires 2035-08-13 F1 · derivative.exercise_date: This option was granted on August 14, 2025 as an option for 4,278 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant. Read SEC document |
| June 04, 2025 Filed Jun 4, 2025 15:23 UTC |
General Resonance LLC10% owner
|
SaleCommon Stock | 600 | $4.04 | $2,424.00 |
DisclosureSEC source: 0001641172-25-013593 · ownership.xml · nonDerivative · entry 1 General Resonance LLC · CIK 0001308627 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 707,992 Read SEC document |
| June 02, 2025 Filed Jun 2, 2025 14:39 UTC |
General Resonance LLC10% owner
|
SaleCommon Stock | 600 | $4.12 | $2,472.60 |
DisclosureSEC source: 0001641172-25-013225 · ownership.xml · nonDerivative · entry 1 General Resonance LLC · CIK 0001308627 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 708,592 Read SEC document |
| May 30, 2025 Filed May 30, 2025 14:40 UTC |
General Resonance LLC10% owner
|
SaleCommon Stock | 410 | $2.80 | $1,148.00 |
DisclosureSEC source: 0001641172-25-012992 · ownership.xml · nonDerivative · entry 1 General Resonance LLC · CIK 0001308627 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 709,192 Read SEC document |
| May 29, 2025 Filed May 29, 2025 15:58 UTC |
General Resonance LLC10% owner
|
SaleCommon Stock | 410 | $2.73 | $1,119.30 |
DisclosureSEC source: 0001641172-25-012845 · ownership.xml · nonDerivative · entry 1 General Resonance LLC · CIK 0001308627 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 709,602 Read SEC document |
| May 28, 2025 Filed May 28, 2025 14:05 UTC |
General Resonance LLC10% owner
|
SaleCommon Stock | 420 | $2.60 | $1,089.90 |
DisclosureSEC source: 0001641172-25-012659 · ownership.xml · nonDerivative · entry 1 General Resonance LLC · CIK 0001308627 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 710,012 Read SEC document |
| May 27, 2025 Filed May 27, 2025 15:29 UTC |
General Resonance LLC10% owner
|
SaleCommon Stock | 420 | $2.45 | $1,029.00 |
DisclosureSEC source: 0001641172-25-012463 · ownership.xml · nonDerivative · entry 1 General Resonance LLC · CIK 0001308627 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 710,432 Read SEC document |
| May 22, 2025 Filed May 23, 2025 19:09 UTC |
Kiernan MatthewDirector
|
GrantStock Options (Right to buy) · Derivative | 5,236 | $0.00 Strike: $2.45 | $0.00 |
DisclosureSEC source: 0001562180-25-004128 · primarydocument.xml · derivative · entry 2 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,236 Underlying: Common Stock · 5,236 shares Expires 2035-05-21 F2 · derivative.exercise_date: This option was granted on May 22, 2025 as an option for 5,236 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $2.45 per share. The options vest immediately upon grant. Read SEC document |
| May 22, 2025 Filed May 23, 2025 19:09 UTC |
Kiernan MatthewDirector
|
GrantStock Options (Right to buy) · Derivative | 1,500 | $0.00 Strike: $2.45 | $0.00 |
DisclosureSEC source: 0001562180-25-004128 · primarydocument.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2035-05-21 F1 · derivative.exercise_date: This option was granted on May 22, 2025 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $2.45 per share. The options vest in 12 equal monthly installments on the 22nd day of each calendar month, beginning June 22, 2025, until such shares are fully vested. Read SEC document |
| May 22, 2025 Filed May 23, 2025 18:14 UTC |
McLaughlin VallerieDirector
|
GrantStock Options (Right to buy) · Derivative | 5,759 | $0.00 Strike: $2.45 | $0.00 |
DisclosureSEC source: 0001562180-25-004122 · primarydocument.xml · derivative · entry 2 McLaughlin Vallerie · CIK 0001876030 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,759 Underlying: Common Stock · 5,759 shares Expires 2035-05-21 F2 · derivative.exercise_date: This option was granted on May 22, 2025 as an option for 5,759 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $2.45 per share. The options vest immediately upon grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.